Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Helicobacter Pylori | Research article

Association between renal function and co-infection with Clonorchis sinensis and Helicobacter pylori: a cross-sectional study

Authors: Weining Xie, Yuanjun Deng, Shengxin Chen, Yifeng Wu, Ye Li, Qinhe Yang

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Studies have shown that liver fluke infections may be associated with kidney injury and that Helicobacter pylori (Hp) may be involved in the pathogenesis of kidney diseases. However, no studies have reported the relationship between co-infection with Clonorchis sinensis (Cs) and Hp and renal function. The aim of this study was to examine the relationship between co-infection with Cs and Hp and estimated glomerular filtration rate (eGFR) in a general population, and gender-related differences were also investigated.

Methods

In the cross-sectional study, 4122 subjects from the Health Examination Center of Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine from January 2017 to December 2018 were enrolled. All participants underwent stool examination for the diagnosis of Cs infection and 13C-urea breath test (UBT) for the diagnosis of Hp infection. Participants were categorized into four groups: (1) co-infection with Cs and Hp group comprising 207 cases (Hp(+) + Cs(+) group), (2) Cs infection group comprising 1392 cases (Hp(−) + Cs(+)group), (3) Hp infection group comprising 275 cases (Hp(+) + Cs(−) group), and (4) non-infection group comprising 2248 cases (Hp(−) + Cs(−) group). Multiple linear regression analysis was performed to evaluate the relationship between co-infection with Cs and Hp and eGFR.

Results

Hp infection without Cs infection was present in 6.67% (275/4122) of subjects, while Cs infection without Hp infection was present in 33.77% (1392/4122) of subjects. Co-infection with Hp and Cs were present in 5.02% (207/4122) of subjects. Median age of the participants was 43 years (IQR 35–51). Most of the participants were male (2955/4122, 71.69%). Median eGFR was 96.61 ml/min/1.73 m2 (IQR 85.05–106.24). Co-infection with Cs and Hp was negatively associated with eGFR after full adjusting (β = − 1.89, 95% CI: − 3.33 to − 0.45, p = 0.01). The relationship remained significant in females (β = − 9.37, 95% CI: − 11.60 to − 7.1, p < 0.001), but not in males.

Conclusion

Our findings suggest that co-infection with Cs and Hp may be associated with reduced renal function in females, but not in males.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis. 2005;5(1):31–41.PubMedCrossRef Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis. 2005;5(1):31–41.PubMedCrossRef
2.
go back to reference Chung PR, Soh CT. Snail-borne parasitic zoonoses in Korea. Southeast Asian J Trop Med Public Health. 1991;22(Supp l):391–517.PubMed Chung PR, Soh CT. Snail-borne parasitic zoonoses in Korea. Southeast Asian J Trop Med Public Health. 1991;22(Supp l):391–517.PubMed
4.
go back to reference Ma YX, Wang H. Epidemiological evolvement of Clonorchiasis sinensis in China for the past 60 years. Int J Med Parasit Dis. 2009;36(5):362–7 (in Chinese). Ma YX, Wang H. Epidemiological evolvement of Clonorchiasis sinensis in China for the past 60 years. Int J Med Parasit Dis. 2009;36(5):362–7 (in Chinese).
5.
go back to reference LQ X, Sun FH, Coordinating Office of the National Survey on the Important Human Parasitic Diseases. A national survey on current status of the important parasitic diseases in human population. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005;23:332–40 in Chinese. LQ X, Sun FH, Coordinating Office of the National Survey on the Important Human Parasitic Diseases. A national survey on current status of the important parasitic diseases in human population. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005;23:332–40 in Chinese.
6.
go back to reference Graham DY, Malaty HM, Evans DJ, Klein PD, Adam E. Epidemiology of H. pylori inan asymptomatic population in the United States: effect of age, race, and socioeconomic status. Gastroenterology. 1991;100(6):1495–14501.PubMedCrossRef Graham DY, Malaty HM, Evans DJ, Klein PD, Adam E. Epidemiology of H. pylori inan asymptomatic population in the United States: effect of age, race, and socioeconomic status. Gastroenterology. 1991;100(6):1495–14501.PubMedCrossRef
7.
go back to reference Bang Cs KYS, Park SH, Kim JB, Baik GH, Suk KT, et al. Additive effect of pronase on the eradication rate of first-line therapy for Helicobacter pylori infection. Gut Liver. 2015;9(3):340–5.PubMed Bang Cs KYS, Park SH, Kim JB, Baik GH, Suk KT, et al. Additive effect of pronase on the eradication rate of first-line therapy for Helicobacter pylori infection. Gut Liver. 2015;9(3):340–5.PubMed
9.
go back to reference Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, crosssectional, screening with the 13C-urea breath test. BMC Public Health. 2013;13(1):1215.PubMedPubMedCentralCrossRef Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, crosssectional, screening with the 13C-urea breath test. BMC Public Health. 2013;13(1):1215.PubMedPubMedCentralCrossRef
10.
go back to reference Uchida T, Miftahussurur M, Pittayanon R, R-k V, Wisedopas N, Ratanachu-ek T, et al. Helicobacter pylori infection in Thailand: a Nationwide study of the CagA phenotype. PLoS One. 2015;10(9):e0136775.PubMedPubMedCentralCrossRef Uchida T, Miftahussurur M, Pittayanon R, R-k V, Wisedopas N, Ratanachu-ek T, et al. Helicobacter pylori infection in Thailand: a Nationwide study of the CagA phenotype. PLoS One. 2015;10(9):e0136775.PubMedPubMedCentralCrossRef
11.
go back to reference Dangtakot R, Pinlaor S, Itthitaetrakool U, Chaidee A, Chomvarin C, Sangka A, et al. Co-infection with Helicobacter pylori and Opisthorchis viverrini enhances the severity of hepatobiliary abnormalities in hamsters. Infect Immun. 2017;85(4):e00009–17.PubMedPubMedCentralCrossRef Dangtakot R, Pinlaor S, Itthitaetrakool U, Chaidee A, Chomvarin C, Sangka A, et al. Co-infection with Helicobacter pylori and Opisthorchis viverrini enhances the severity of hepatobiliary abnormalities in hamsters. Infect Immun. 2017;85(4):e00009–17.PubMedPubMedCentralCrossRef
12.
go back to reference Deenonpoe R, Chomvarin C, Pairojkul C, Chamgramol Y, Loukas A, Brindley PJ, et al. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter. Asian Pac J Cancer Prev. 2015;16(5):1751–8.PubMedCrossRef Deenonpoe R, Chomvarin C, Pairojkul C, Chamgramol Y, Loukas A, Brindley PJ, et al. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter. Asian Pac J Cancer Prev. 2015;16(5):1751–8.PubMedCrossRef
13.
go back to reference Ozgur O, Boyacioglu S, Ozdogan M, Gur G, Telatar H, Haberal M. Helicobacter pylori infection in hemodialysis patients and renal transplant recipients. Nephrol Dial Transplant. 1997;12(2):289–91.PubMedCrossRef Ozgur O, Boyacioglu S, Ozdogan M, Gur G, Telatar H, Haberal M. Helicobacter pylori infection in hemodialysis patients and renal transplant recipients. Nephrol Dial Transplant. 1997;12(2):289–91.PubMedCrossRef
14.
go back to reference Gür G, Boyacioglu S, Gül C, Turan M, Gürsoy M, Baysal C, et al. Impact of Helicobacter pylori infection on serum gastrin in hemodialysis patients. Nephrol Dial Transplant. 1999;14(11):2688–91.PubMedCrossRef Gür G, Boyacioglu S, Gül C, Turan M, Gürsoy M, Baysal C, et al. Impact of Helicobacter pylori infection on serum gastrin in hemodialysis patients. Nephrol Dial Transplant. 1999;14(11):2688–91.PubMedCrossRef
15.
go back to reference Zhu TT, Wang L, Wang HL, He Y, Ma X, Fan JM. Helicobacter pylori participates in the pathogenesis of IgA nephropathy. Ren Fail. 2016;38(9):1398–404.PubMedCrossRef Zhu TT, Wang L, Wang HL, He Y, Ma X, Fan JM. Helicobacter pylori participates in the pathogenesis of IgA nephropathy. Ren Fail. 2016;38(9):1398–404.PubMedCrossRef
16.
go back to reference Yang M, Li FG, Xie XS, Wang SQ, Fan JM. CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells. Biochem Biophys Res Commun. 2014;444(2):276–81.PubMedCrossRef Yang M, Li FG, Xie XS, Wang SQ, Fan JM. CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells. Biochem Biophys Res Commun. 2014;444(2):276–81.PubMedCrossRef
17.
go back to reference Fang YY, Chen YD, Li XM, Wu J, Zhang QM, Ruan CW. Current prevalence of Clonorchis sinensis infection in endemic areas of China. Zhong guo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008;26(2):99–103 109. (in Chinese). Fang YY, Chen YD, Li XM, Wu J, Zhang QM, Ruan CW. Current prevalence of Clonorchis sinensis infection in endemic areas of China. Zhong guo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008;26(2):99–103 109. (in Chinese).
18.
go back to reference WHO Expert Committee. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser. 2002;912:i–vi 1–57. WHO Expert Committee. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser. 2002;912:i–vi 1–57.
19.
go back to reference WHO. Soil-transmitted helminthiases: eliminating as public health problem soil-transmitted helminthiases in children: progress report 2001–2010 and strategic plan 2011–2020; 2012. WHO. Soil-transmitted helminthiases: eliminating as public health problem soil-transmitted helminthiases in children: progress report 2001–2010 and strategic plan 2011–2020; 2012.
20.
go back to reference Connor SJ, Seow F, Ngu MC, Katelaris PH. The effect of dosing with omeprazole on the accuracy of the 13C-urea breath test in Helicobacter pylori-infected subjects. Aliment Pharmacol Ther. 1999;13(10):1287–93.PubMedCrossRef Connor SJ, Seow F, Ngu MC, Katelaris PH. The effect of dosing with omeprazole on the accuracy of the 13C-urea breath test in Helicobacter pylori-infected subjects. Aliment Pharmacol Ther. 1999;13(10):1287–93.PubMedCrossRef
21.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.PubMedPubMedCentralCrossRef Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.PubMedPubMedCentralCrossRef
22.
go back to reference IARC. A review of human carcinogens: Opisthorchis viverrini and Clonorchis sinensis. IARC Monogr Eval Carcinog Risks Hum. 2012;100:341–70. IARC. A review of human carcinogens: Opisthorchis viverrini and Clonorchis sinensis. IARC Monogr Eval Carcinog Risks Hum. 2012;100:341–70.
23.
go back to reference Sithithaworn P, Andrews RH, Van De N, Wongsaroj T, Sinuon M, Odermatt P, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int. 2012;61(1):10–6.PubMedCrossRef Sithithaworn P, Andrews RH, Van De N, Wongsaroj T, Sinuon M, Odermatt P, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int. 2012;61(1):10–6.PubMedCrossRef
24.
go back to reference Mairiang E, Haswell-Elkins MR, Mairiang P, Sithithaworn P, Elkins DB. Reversal of biliary tract abnormalities associated with Opisthorchis viverrini infection following praziquantel treatment. Trans R Soc Trop Med Hyg. 1993;87(2):194–7.PubMedCrossRef Mairiang E, Haswell-Elkins MR, Mairiang P, Sithithaworn P, Elkins DB. Reversal of biliary tract abnormalities associated with Opisthorchis viverrini infection following praziquantel treatment. Trans R Soc Trop Med Hyg. 1993;87(2):194–7.PubMedCrossRef
26.
go back to reference Boonpucknavig S, Boonpucknavig V, Tanvanich S, Doungchawee G, Thamavit W. Development of immune-complex glomerulonephritis and amyloidosis in Syrian golden hamsters infected with Opisthorchis viverrini. J Med Assoc Thai. 1992;75(Suppl 1):7–19.PubMed Boonpucknavig S, Boonpucknavig V, Tanvanich S, Doungchawee G, Thamavit W. Development of immune-complex glomerulonephritis and amyloidosis in Syrian golden hamsters infected with Opisthorchis viverrini. J Med Assoc Thai. 1992;75(Suppl 1):7–19.PubMed
27.
go back to reference Boonpucknavig V, Soontornniyomkij V. Pathology of renal diseases in the tropics. Semin Nephrol. 2003;23(1):88–106.PubMedCrossRef Boonpucknavig V, Soontornniyomkij V. Pathology of renal diseases in the tropics. Semin Nephrol. 2003;23(1):88–106.PubMedCrossRef
28.
go back to reference Saichua P, Sithithaworn P, Jariwala AR, Deimert DJ, Sithithaworn J, Sripa B, et al. Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and Hepatobiliary pathologies from chronic Opisthorchiasis. PLoS Negl Trop Dis. 2013;7(5):e2228.PubMedPubMedCentralCrossRef Saichua P, Sithithaworn P, Jariwala AR, Deimert DJ, Sithithaworn J, Sripa B, et al. Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and Hepatobiliary pathologies from chronic Opisthorchiasis. PLoS Negl Trop Dis. 2013;7(5):e2228.PubMedPubMedCentralCrossRef
29.
go back to reference Gray BM, Fontaine CA, Poe SA, Eaton KA. Complex T cell interactions contribute to helicobacter pylori gastritis in mice. Infect Immun. 2013;81(3):740–52.PubMedPubMedCentralCrossRef Gray BM, Fontaine CA, Poe SA, Eaton KA. Complex T cell interactions contribute to helicobacter pylori gastritis in mice. Infect Immun. 2013;81(3):740–52.PubMedPubMedCentralCrossRef
30.
go back to reference Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H. Gastric parietal cell antibodies, Helicobacter Pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013;22(5):821–6.PubMedCrossRef Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H. Gastric parietal cell antibodies, Helicobacter Pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013;22(5):821–6.PubMedCrossRef
31.
go back to reference Li KJ, Chen L. Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta analysis. Int Urol Nephrol. 2019;51(8):1361–70.PubMedCrossRef Li KJ, Chen L. Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta analysis. Int Urol Nephrol. 2019;51(8):1361–70.PubMedCrossRef
32.
go back to reference Nakajima F, Sakaguchi M, Oka H, Kawase Y, Shibahara N, Inoue T, et al. Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology. 2004;9(2):73–6.PubMedCrossRef Nakajima F, Sakaguchi M, Oka H, Kawase Y, Shibahara N, Inoue T, et al. Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology. 2004;9(2):73–6.PubMedCrossRef
33.
go back to reference Mortazavi F, Rafeey M. Endoscopic findings and Helicobacter pylori in children on long-term hemodialysis. Pak J Biol Sci. 2008;11(14):1840–3.PubMedCrossRef Mortazavi F, Rafeey M. Endoscopic findings and Helicobacter pylori in children on long-term hemodialysis. Pak J Biol Sci. 2008;11(14):1840–3.PubMedCrossRef
34.
go back to reference Antoniou S, Dimitriadis A, Kliridou M, Pavlitou K, Batzili H, Malaka E. Prevalence of Helicobacter pylori antibodies in CAPD patients. Nephron. 1997;75(3):358–9.PubMedCrossRef Antoniou S, Dimitriadis A, Kliridou M, Pavlitou K, Batzili H, Malaka E. Prevalence of Helicobacter pylori antibodies in CAPD patients. Nephron. 1997;75(3):358–9.PubMedCrossRef
35.
go back to reference Ozgur O, Boyacioglu S, Ozdogan M, Gür TH, Haberal M. Helicobacter pylori infection in hemodialysis patients and renal transplant recipients. Nephrol Dial Transplant. 1997;12(2):289–91.PubMedCrossRef Ozgur O, Boyacioglu S, Ozdogan M, Gür TH, Haberal M. Helicobacter pylori infection in hemodialysis patients and renal transplant recipients. Nephrol Dial Transplant. 1997;12(2):289–91.PubMedCrossRef
36.
go back to reference Gür G, Boyacioglu S, Gül C, Turan M, Gürsoy M, Baysal C, et al. Impact of Helicobacter pylori infection on serum gastrin in hemodialysis patients. Nephrol Dial Transplant. 1999;14(11):2688–91.PubMedCrossRef Gür G, Boyacioglu S, Gül C, Turan M, Gürsoy M, Baysal C, et al. Impact of Helicobacter pylori infection on serum gastrin in hemodialysis patients. Nephrol Dial Transplant. 1999;14(11):2688–91.PubMedCrossRef
37.
go back to reference Rasmi Y, Farshid S, Makhdomi K. Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection. Saudi J Kidney Dis Transpl. 2012;23(3):489–92.PubMed Rasmi Y, Farshid S, Makhdomi K. Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection. Saudi J Kidney Dis Transpl. 2012;23(3):489–92.PubMed
38.
go back to reference Tamadon MR, Saberi M, Soleimani A, Ghorbani R, Semnani V, Malek F, et al. Evaluation of noninvasive tests for diagnosis of Helicobacter pylori infection in hemodialysis patients. J Nephropathol. 2013;2(4):249–53.PubMedPubMedCentral Tamadon MR, Saberi M, Soleimani A, Ghorbani R, Semnani V, Malek F, et al. Evaluation of noninvasive tests for diagnosis of Helicobacter pylori infection in hemodialysis patients. J Nephropathol. 2013;2(4):249–53.PubMedPubMedCentral
39.
go back to reference Shirazian S, Radhakrishnan J. Gastrointestinal disorders and renal failure: exploring the connection. Nat Rev Nephrol. 2010;6(8):480–92.PubMedCrossRef Shirazian S, Radhakrishnan J. Gastrointestinal disorders and renal failure: exploring the connection. Nat Rev Nephrol. 2010;6(8):480–92.PubMedCrossRef
40.
go back to reference Moriyama T, Matsumoto T, Hirakawa K, Ikeda H, Tsuruya K, Hirakata H, et al. Helicobacter pylori status and esophagogastroduodenal mucosal lesions in patients with end-stage renal failure on maintenance hemodialysis. J Gastroenterol. 2010;45(5):515–22.PubMedCrossRef Moriyama T, Matsumoto T, Hirakawa K, Ikeda H, Tsuruya K, Hirakata H, et al. Helicobacter pylori status and esophagogastroduodenal mucosal lesions in patients with end-stage renal failure on maintenance hemodialysis. J Gastroenterol. 2010;45(5):515–22.PubMedCrossRef
41.
go back to reference Li KJ, Chen L. Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta analysis. Int Urol Nephrol. 2019;51(8):1361–70.PubMedCrossRef Li KJ, Chen L. Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta analysis. Int Urol Nephrol. 2019;51(8):1361–70.PubMedCrossRef
42.
go back to reference Shi Y, Duan JY, Liu DW, Qiao YJ, Han QX, Pan SK, et al. Helicobacter pylori infection is associated with occurrence of proteinuria in type 2 diabetes patients: a systemic review and meta-analysis. Chin Med J (Engl). 2018;131(22):2734–40.CrossRef Shi Y, Duan JY, Liu DW, Qiao YJ, Han QX, Pan SK, et al. Helicobacter pylori infection is associated with occurrence of proteinuria in type 2 diabetes patients: a systemic review and meta-analysis. Chin Med J (Engl). 2018;131(22):2734–40.CrossRef
43.
go back to reference Kong X, Xu D, Li F, Ma X, Su H, Xu D. Association of H. pylori infection with chronic kidney disease among Chinese adults. Int Urol Nephrol. 2017;49(5):845–50.PubMedCrossRef Kong X, Xu D, Li F, Ma X, Su H, Xu D. Association of H. pylori infection with chronic kidney disease among Chinese adults. Int Urol Nephrol. 2017;49(5):845–50.PubMedCrossRef
44.
go back to reference Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med. 2008;5(Suppl A):S3–S10.PubMedCrossRef Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med. 2008;5(Suppl A):S3–S10.PubMedCrossRef
45.
46.
go back to reference Wang H, Xu J, Zhang X, Ren YL, Cheng M, Guo ZL, et al. Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study. Lupus. 2018;27:545–55.PubMedCrossRef Wang H, Xu J, Zhang X, Ren YL, Cheng M, Guo ZL, et al. Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study. Lupus. 2018;27:545–55.PubMedCrossRef
Metadata
Title
Association between renal function and co-infection with Clonorchis sinensis and Helicobacter pylori: a cross-sectional study
Authors
Weining Xie
Yuanjun Deng
Shengxin Chen
Yifeng Wu
Ye Li
Qinhe Yang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05616-0

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.